Drugs.com - FDA MedWatch Alerts

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk...

Feb 9, 2025 - 21:44
 0
Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter
Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk...
Read More

Tags:

Previous Article

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal S...

Next Article

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Box...

Related Posts

FDA Warns Consumers to Not Purchase or Use Unapproved Inhalant Products Marketed for Alertness and Energy Boosting

FDA Warns Consumers to Not Purchase or Use Unapproved I...

Feb 9, 2025  0

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

Alvogen Issues Voluntary Nationwide Recall for One Lot ...

Feb 9, 2025  0

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic ...

Feb 9, 2025  0